Theresa Iacobucci

About

Terry received her BS in Chemical Engineering at Rutgers University - College of Engineering and maintains her, Professional Engineer (P.E.) license in Pennsylvania. She began her career as an engineer with the Philadelphia Water Department, working on infrastructure and compliance with the Safe Drinking Water and Clean Water Acts. Her career in the pharmaceutical industry, ranges from a ‘packaging technician’ at a small boutique clinical packaging site, to managing clinical supplies first for investigator-sponsored trials at Sanofi, joining Bayer’s Phase 1 clinical development team, developing the clinical supplies plan to support the growing portfolio of ISTs, Expanded Access and pharmaceutical partnerships at TESARO. When GSK acquired TESARO in 2019, Terry was responsible for management of the entire clinical supply portfolio of the TESARO assets, including the oversight of the outsourced clinical supply team and clinical packaging vendors. In April 2021, Terry moved to Morphic Therapeutics to develop a clinical supply chain for their promising portfolio. In August 2024, Terry’s new journey began when Eli Lilly and Company acquired Morphic Therapeutics. She continues to support the legacy Morphic studies and has begun integrating with the Lilly team. Terry has been an active member of GCSG for 15 years. In 2018, Terry joined the GCSG Expanded Access E- team (EART) and continues to work with the team on development of tools to support clinical supply professionals. Previous presentations at GCSG include Investigator Sponsored Trials and Expanded Access as well as Boot Camps for IRT and for Expanded Access.

Contact

Industry Related Information